According to INmune Bio's latest financial reports the company's current earnings (TTM) are -A$56.61 M. In 2023 the company made an earning of -A$45.01 M a decrease over its 2022 earnings that were of -A$40.95 M.The earnings displayed on this page is the company's Pretax Income.